» Authors » Maria L Mora

Maria L Mora

Explore the profile of Maria L Mora including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 42
Citations 759
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang Q, Acuna J, Inostroza N, Duran P, Mora M, Sadowsky M, et al.
Front Microbiol . 2020 Jun; 11:1036. PMID: 32582056
Climate change directly affecting the Antarctic Peninsula has been reported to induce the successful colonization of ice-free lands by two Antarctic vascular plants ( and ). While studies have revealed...
2.
Lorente L, Lecuona M, Jimenez A, Cabrera J, Santacreu R, Lorenzo L, et al.
Am J Infect Control . 2016 Jul; 44(12):1526-1529. PMID: 27378009
Background: Chlorhexidine-silver sulfadiazine (CHSS)-impregnated catheters have been found to decrease the risk of catheter-related bloodstream infection (CRBSI) and central venous catheter (CVC)-related costs. However, there are no published data about...
3.
4.
Lorente L, Lecuona M, Jimenez A, Raja L, Cabrera J, Gonzalez O, et al.
Am J Infect Control . 2015 Sep; 44(1):50-3. PMID: 26412482
Background: The objective of this study was to compare the incidence of catheter-related bloodstream infection (CRBSI) with the use of second-generation chlorhexidine-silver sulfadiazine (CHSS)-impregnated catheters, rifampicin-miconazole (RM)-impregnated catheters, and standard...
5.
Lorente L, Lecuona M, Jimenez A, Lorenzo L, Santacreu R, Ramos S, et al.
Am J Infect Control . 2015 May; 43(7):711-4. PMID: 25934065
Background: Cost-effectiveness analyses show that chlorhexidine-silver sulfadiazine (CHSS)-impregnated catheters reduce catheter-related bloodstream infection (CRBSI) and central venous catheter (CVC)-related costs. However, no studies have reported the efficiency of CHSS-impregnated catheters...
6.
Lorente L, Lecuona M, Jimenez A, Lorenzo L, Diosdado S, Marca L, et al.
Am J Infect Control . 2014 Oct; 42(10):1130-2. PMID: 25278411
Sixty-four patients with chlorhexidine-silver sulfadiazine-impregnated catheters had a lower rate of catheter-related bloodstream infection and lower central venous catheter-related costs per catheter day than 190 patients with a standard catheter.
7.
Lorente L, Lecuona M, Jimenez A, Cabrera J, Mora M
Am J Infect Control . 2014 Oct; 42(10):1101-5. PMID: 25278402
Background: Preventive strategies to reduce ventilator-associated respiratory infection (VARI) include the use of an endotracheal tube incorporating a lumen for subglottic secretion drainage (SSD) and a system for continuous control...
8.
Lorente L, Lecuona M, Jimenez A, Lorenzo L, Roca I, Cabrera J, et al.
Crit Care . 2014 Apr; 18(2):R77. PMID: 24751286
Introduction: The use of a system for continuous control of endotracheal tube cuff pressure reduced the incidence of ventilator-associated pneumonia (VAP) in one randomized controlled trial (RCT) with 112 patients...
9.
Lorente L, Martin M, Lopez P, Ramos L, Blanquer J, Caceres J, et al.
PLoS One . 2014 Apr; 9(4):e94370. PMID: 24728097
Objective: Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) play a role in neuroinflammation after brain trauma injury (TBI). Previous studies with small sample size have reported higher...
10.
Lorente L, Lecuona M, Jimenez A, Santacreu R, Raja L, Gonzalez O, et al.
Am J Infect Control . 2014 Mar; 42(3):321-4. PMID: 24581021
Background: Previous cost-effectiveness analyses have found that the use of chlorhexidine-silver sulfadiazine (CHSS)-impregnated catheters is associated with decreased catheter-related bloodstream infections (CRBSI) and central venous catheter (CVC)-related costs. However, in...